热门资讯> 正文
Happy Biofarma GAAP每股收益为-0.09美元
2025-10-30 05:49
- Helix Biopharma press release (OTCPK:HBPCF): FY GAAP EPS of -$0.09.
- As at July 31, 2025, the Company’s cash reserves of $65,000 are insufficient to meet anticipated cash needs for working capital and capital expenditures through the next twelve months, nor are they sufficient to see the current research and development initiates through to completion. To theextent that the Company does not believe it has sufficient liquidity to meet its current obligations, management considers securing additional funds primarily through equity arrangements to be of utmost importance.
More on Helix BioPharma Corp.
- Seeking Alpha’s Quant Rating on Helix BioPharma Corp.
- Financial information for Helix BioPharma Corp.
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
